%27%20fill-opacity%3D%27.5%27%3E%3Cellipse%20fill%3D%22%23000008%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(138.8%20-38.7%20272.1)%20scale(188.76083%20385.45746)%22%2F%3E%3Cellipse%20fill%3D%22%23a4a5a3%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22matrix(-13.612%20567.89053%20-249.89868%20-5.98992%20590.9%20107)%22%2F%3E%3Cellipse%20fill%3D%22%230f100e%22%20fill-opacity%3D%22.5%22%20rx%3D%221%22%20ry%3D%221%22%20transform%3D%22rotate(170.4%20452.8%20348.1)%20scale(163.96043%20228.33472)%22%2F%3E%3Cpath%20fill%3D%22%23b8b8b8%22%20fill-opacity%3D%22.5%22%20d%3D%22M609.6%20369.1L757.3-65.4%20453.5%20234.1z%22%2F%3E%3C%2Fg%3E%3C%2Fsvg%3E)
by G-Pact | Oct 25, 2016 | Legislative News
Domperidone is a drug that has been used to treat patients with gastroparesis. It is not available by prescription in the United States, and while it was once able to be formulated in compounding pharmacies, that practice has been banned by the FDA. Domperidone is... by G-Pact | Oct 6, 2016 | Legislative News
Right To Try is a legislative effort to expand the ability of terminally ill patients to gain access to experimental medicines. It would prohibit the federal government, including the US Food and Drug Administration, from taking any action to prevent patient access to...
